Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103249
First IPO Date
August 03, 1995
| Name | Title | Pay | Year Born |
| Thomas Schinecker | Group Chief Executive Officer | 3.87M | 1975 |
| Maria Cristina A. Wilbur | Chief People Officer | 2.92M | 1967 |
| Alan Hippe | Chief Financial Officer | 4.11M | 1967 |
| Severin Schwan | Executive Chairman | 7.51M | 1967 |
| Bruno Eschli | Head of Investor Relations | 0 | N/A |
| Nicolas Dunant | Head of Group Media Relations | 0 | N/A |
| Nina Schwab-Hautzinger | Head of Group Communications | 0 | 1975 |
| Boris L. Zaitra | Head of Corporate Business Development | 0 | 1972 |
| Pascale Schmidt | Chief Compliance Officer | 0 | 1973 |
| Wafaa Mamilli | Chief Digital & Technology Officer | 0 | 1967 |
| Claudia Bockstiegel | General Counsel | 0 | 1964 |
Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.